Physician profile
John Goddard
NPI 1063489425
$6,624.47
in general payments reported to CMS, 2019-2025
27 companies · $712 in 2025
The $712 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,568 · 2020: $194 · 2021: $555 · 2022: $233 · 2023: $700 · 2024: $662 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,685.76 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $572.02 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $537.89 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Synergy |
| Kestra Medical Technology Services, INC. | $325.53 | 2024-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $290.05 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $233.73 | 2019-2024 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.36 | 2019-2024 | Jardiance |
| Chiesi USA, INC. | $204.96 | 2019 | |
| Zoll Circulation INC | $203.43 | 2023-2024 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Abbott Laboratories | $162.61 | 2019-2024 | Perclose Prostyle, Diamondback Coronary |
| Penumbra, INC. | $144.32 | 2021 | |
| Livanova USA, INC. | $142.53 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $124.23 | 2019-2024 | Eliquis |
| Abiomed | $106.92 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $104.08 | 2019-2023 | Xarelto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $82.04 | 2019-2020 | |
| Stryker Corporation | $78.64 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Pfizer INC. | $73.50 | 2022-2024 | |
| Amgen INC. | $66.62 | 2019-2020 | |
| Medtronic, INC. | $56.54 | 2022 | |
| Amarin Pharma, INC. | $54.55 | 2020-2021 | |
| Shockwave Medical, INC | $47.96 | 2020 | |
| Smith+Nephew, INC. | $34.69 | 2025 | Renasys Go V2 Home |
| Novo Nordisk INC | $18.91 | 2025 | Wegovy |
| Getinge USA Sales, LLC | $15.50 | 2019 | |
| Lundbeck LLC | $15.02 | 2019 | |
| Cardiovascular Systems INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Goddard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.